SafeSleeve was founded in California by two Engineering graduates (University of Cal Poly San Luis Obispo) Cary and Alaey, with a desire to make a difference. They wanted to develop a product to help simplify, protect, and enhance the lives of their increasingly busy, tech dependent peers, family and friends. This is apparent in the highly efficient and useful, yet stylish designs and branding of SafeSleeve products.
Today’s report, the final one, was about a decade in the making and is the last of several versions that have been released since preliminary results were presented in May 2016. It represents the consensus of NTP scientists and a group of external reviewers, according to the release. In the future, the NTP plans to conduct studies in smaller exposure chambers and to use biomarkers such as DNA damage to gauge cancer risk. These changes in the experimental setup should mean that future studies will take less time.
“One thing all these conditions have in common is a disruption, to varying degrees, of intercellular communication. When we were growing up, TV antennas were on top of our houses and such waves were up in the sky. Cell phones and Wi-Fi have brought those things down to the street, integrated them into the environment, and that’s absolutely new. The recognition mechanism, where protein vibration sensors on the cell membrane pick up a signal and interpret it as an invader, only works because the body recognizes something it’s never seen before.”
Morbidity and mortality among study participants who have brain cancer. Gliomas are particularly difficult to study, for example, because of their high death rate and the short survival of people who develop these tumors. Patients who survive initial treatment are often impaired, which may affect their responses to questions. Furthermore, for people who have died, next-of-kin are often less familiar with the cell phone use patterns of their deceased family member and may not accurately describe their patterns of use to an interviewer.
To find out about the state of research on the link between phones and cancer, we spoke with Jonathan Samet, dean of the Colorado School of Public Health and an expert in phone radiation who led a World Health Organization working group on the subject. In 2011, the WHO group deemed phone radiation “possibly carcinogenic,” which is less certain than other classifications, but isn’t an outright “no” either. Six years later, Samet said the evidence in either direction is still mixed and that for the time being, there remains “some indication” of risk.
This 2017 review, published in Neurological Sciences, looked at case-control studies on cellphone use, focusing on glioma, meningioma, and acoustic neuromas. This review was interesting because the researchers divided the studies by quality, and higher-quality studies — which tended to be funded by the government and not the cellphone industry — showed a trend toward an increased risk of brain tumors, while lower-quality studies did not. Overall, though, their meta-analysis found an increased risk of brain cancers (mostly gliomas) among people who were using cellphones for 10 or more years, and no increase in the risk of acoustic neuroma.
Pong Research also makes cases for the iPad and its technology is arguably better suited for that. Why? Because serving as a stand to prop up your iPad or tablet, it means you don’t really need to hold it. That’s an ideal setup because higher amounts of radiation are going out the back, versus the front of the screen which you are touching with your fingers and palms.
Recall bias, which can occur when data about prior habits and exposures are collected from study participants using questionnaires administered after diagnosis of a disease in some of the participants. It is possible that study participants who have brain tumors may remember their cell phone use differently from individuals without brain tumors. Many epidemiologic studies of cell phone use and brain cancer risk lack verifiable data about the total amount of cell phone use over time. In addition, people who develop a brain tumor may have a tendency to recall cell phone use mostly on the same side of the head where their tumor was found, regardless of whether they actually used their phone on that side of the head a lot or only a little.
Today, the computer and phone have merged into one device that fits in the palm of your hand. A smartphone is essentially a small computer, yet has many times the computing power of traditional computers. There are no cords to connect you to a base. When turned on in your pocket or being used against your head, the cell phone touches some of the most sensitive parts of the body. Although the cell phone produces lower levels of radiation then past computers, they are now used much closer to the body and for longer periods of time, thus creating more health risks than in the past.
I don’t understand why only the lab tests are accurate. I just purchases two SafeSleeve cases and tested them myself with the same meter they use on their website in the promotional video. I made sure there were no other electronics nearby and I had the meter at zero without the cell phone next to it. I did not get the results they show in the video. I tested the phone with and without the case and it did not make any difference. The meter was peaking no mater what, with the flap opened or closed. If the meter is picking up radiation through the case, then my head is too. SafeSleeve is willing to reimburse me for the cases, but I am concerned that this might be a case of false advertising.
Researchers have carried out several types of epidemiologic studies in humans to investigate the possibility of a relationship between cell phone use and the risk of malignant (cancerous) brain tumors, such as gliomas, as well as benign (noncancerous) tumors, such as acoustic neuroma (tumors in the cells of the nerve responsible for hearing that are also known as vestibular schwannomas), meningiomas (usually benign tumors in the membranes that cover and protect the brain and spinal cord), and parotid gland tumors (tumors in the salivary glands) (3).